SRPT FY 2014 Earnings — Sarepta Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

SRPTSarepta Therapeutics, Inc.

$2B

FY 2014 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$10M-31.4% YoY

Gross Profit

-$84M-864.5% margin

Operating Income

-$134M-1371.2% margin

Net Income

-$136M-1391.7% margin

EPS (Diluted)

$-3.39

Cash Flow

Operating Cash Flow

-$129M

Free Cash Flow

-$155M

Stock-Based Comp.

$20M

Balance Sheet

Total Assets

$295M

Total Liabilities

$47M

Stockholders' Equity

$248M

Cash & Equivalents

$74M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$14M	-31.4%
Gross Profit	-$84M	-$76M	-10.9%
Operating Income	-$134M	-$90M	-48.2%
Net Income	-$136M	-$112M	-21.3%